deltatrials
Unknown PHASE2 INTERVENTIONAL NCT00010075

Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer

Study Of The Survival Without Degradation To The Quality Of Life During Chemotherapy For Metastatic Breast Cancer In Women

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group

Conditions Breast Cancer
Interventions fluorouracil leucovorin calcium mitoxantrone hydrochloride
Updated 7 times since 2017 Last updated: Jul 23, 2008 Started: Jan 31, 2000
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Breast Cancer, this trial is ongoing. The trial is conducted by GERCOR - Multidisciplinary Oncology Cooperative Group and has accumulated 7 data snapshots since 2000. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2018 · 13 months · monthly snapshotUnknown Status~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 19 months · monthly snapshotUnknown~Jan 2026 – present · 3 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Jan 2026 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Present [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

▶ Show 2 earlier versions

  1. Feb 2018 — Jun 2018 [monthly]

    Unknown Status PHASE2

  2. Jan 2017 — Feb 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GERCOR - Multidisciplinary Oncology Cooperative Group
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations